Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Scott Juda currently holds 32,500 shares of Inmune Bio, Inc. (INMB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott Juda has been a net buyer of INMB stock. They have purchased $459.0K and sold $0 worth of shares.
Scott Juda's most recent insider trade was on Dec 5, 2024, when they sold 32,500 shares at $0.00 per share.
Scott Juda serves as Executive at Inmune Bio, Inc. (INMB). They have executed 12 insider transactions totaling $459.0K over their tenure at the company.
Scott Juda holds the position of Executive at Inmune Bio, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Scott Juda has shown a buying trading pattern, with $459.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Scott Juda was on Apr 19, 2024, when they purchased $246.3K worth of INMB shares. This transaction involved 29,603 shares at $8.32 per share.
Scott Juda currently owns 32,500 shares of Inmune Bio, Inc. (INMB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Scott Juda's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Scott Juda has 12 Form 4 filings on record as an insider at Inmune Bio, Inc..
Set alerts for Scott Juda and 40,000+ other insiders.